Exelixis to Investors: "Wait for It... No, Seriously, Wait for It!"
Exelixis' shareholders are about to have their patience tested, whether they like it or not.
Why Exelixis, Inc. Shares Slumped Today
Exelixis Inc.'s FDA review for approval of cobimetinib has been delayed until November.
Small Cap Stocks to Watch in Biotech
Small cap stocks can be some of the most intriguing buys for investors. Here are three from the biotech sector that you may want to add to your watchlist.
The Drug Development Process Explained in Detail and How It Impacts Your Investments
A detailed step-by-step guide on how a drug goes from a concept in the lab to a product on pharmacy shelves, and how the drug development process can affect your investments.
3 Biotech Stocks to Buy As the Greek Tragedy Unfolds
Exelixis, Enanta Pharmaceuticals, and Isis Pharmaceuticals are three names in biotech I'm closely watching in case they fall as a result of the financial crisis in Greece.